全文获取类型
收费全文 | 37498篇 |
免费 | 3907篇 |
国内免费 | 636篇 |
专业分类
耳鼻咽喉 | 247篇 |
儿科学 | 785篇 |
妇产科学 | 1395篇 |
基础医学 | 2932篇 |
口腔科学 | 258篇 |
临床医学 | 3550篇 |
内科学 | 7768篇 |
皮肤病学 | 262篇 |
神经病学 | 1106篇 |
特种医学 | 688篇 |
外国民族医学 | 1篇 |
外科学 | 4329篇 |
综合类 | 2954篇 |
一般理论 | 3篇 |
预防医学 | 4568篇 |
眼科学 | 84篇 |
药学 | 2224篇 |
10篇 | |
中国医学 | 489篇 |
肿瘤学 | 8388篇 |
出版年
2024年 | 60篇 |
2023年 | 940篇 |
2022年 | 1646篇 |
2021年 | 2370篇 |
2020年 | 1829篇 |
2019年 | 2331篇 |
2018年 | 2272篇 |
2017年 | 1886篇 |
2016年 | 1541篇 |
2015年 | 1565篇 |
2014年 | 2840篇 |
2013年 | 2952篇 |
2012年 | 1846篇 |
2011年 | 2026篇 |
2010年 | 1458篇 |
2009年 | 1579篇 |
2008年 | 1805篇 |
2007年 | 1547篇 |
2006年 | 1301篇 |
2005年 | 1011篇 |
2004年 | 938篇 |
2003年 | 732篇 |
2002年 | 523篇 |
2001年 | 515篇 |
2000年 | 417篇 |
1999年 | 390篇 |
1998年 | 343篇 |
1997年 | 325篇 |
1996年 | 323篇 |
1995年 | 269篇 |
1994年 | 263篇 |
1993年 | 216篇 |
1992年 | 168篇 |
1991年 | 138篇 |
1990年 | 120篇 |
1989年 | 121篇 |
1988年 | 112篇 |
1987年 | 97篇 |
1986年 | 104篇 |
1985年 | 163篇 |
1984年 | 175篇 |
1983年 | 128篇 |
1982年 | 153篇 |
1981年 | 103篇 |
1980年 | 86篇 |
1979年 | 91篇 |
1978年 | 55篇 |
1977年 | 33篇 |
1976年 | 40篇 |
1975年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
AIMS: To investigate the association between estimated glomerular filtration rate (eGFR) and total and cardiovascular mortality in a population-based cohort of diabetic subjects. METHODS: A longitudinal study using a population-based district diabetes register comprising 3288 subjects in South Tees, UK. The eGFR was calculated using the Modification of Diet in Renal Disease (MDRD) study equation. Patients were stratified by baseline eGFR into five stages as per the National Kidney Foundation guidelines: Stage 1, eGFR > 90; Stage 2, eGFR 60-89; Stage 3, eGFR 30-59; Stage 4, eGFR 15-29; and Stage 5, eGFR < 15 ml/min per 1.73 m(2). Main outcome was all-cause and cardiovascular mortality between 1 January 1994 and 31 July 2004. RESULTS: At baseline, mean age (58.4 years) differed between groups. Persons with lower eGFR were older (P < 0.001). Thirty-six percent (n = 1193, males 56%) had died by 10 years (cardiovascular cause in 60%). Median follow-up was 10.5 years amounting to 28 342 person years. Stages 4 and 5 (eGFR 相似文献
42.
1142例胃癌切除术围手术期死亡因素分析 总被引:11,自引:0,他引:11
目的研究影响胃癌围手术期死亡的主要因素,为指导选择合理的切除范围和手术方式提供依据。方法回顾1989年1月至2004年3月胃癌手术后1142例患者的临床资料,按照不同年代分为3组,第1组:1989年1月至1994年1月,405例;第2组:1994年2月至1999年1月,377例;第3组:1999年2月至2004年3月,360例。比较3组间的围手术期死亡率,采用Logistic多因素回归分析研究影响手术死亡率的危险因素。结果全组患者术后并发症发生率和死亡率分别为11.2%(128/1142)和3.6%(41/1142)。第1、2、3组的术后并发症发生率依次为13.1%、10.1%和10.3%;3组比较,P>0.05。3组手术死亡率依次为4.7%、3.4%和2.5%,3组比较,P>0.05。术后最常见的并发症是吻合口瘘(24.2%,31/128),影响手术死亡的主要因素为临床Ⅳ期、姑息性切除术、联合脏器切除及术前合并症的存在(P<0.05)。Logistic多元回归分析显示淋巴结的清除范围和手术方式不是影响手术死亡的主要因素(P>0.05)。结论胃癌晚期患者手术死亡率高,对胃癌Ⅳ期患者行姑息性切除手术时应避免施行不必要的淋巴结清除及联合脏器切除术。 相似文献
43.
44.
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature 总被引:12,自引:0,他引:12
Kai Temming Raymond M. Schiffelers Grietje Molema Robbert J. Kok 《Drug Resistance Updates》2005,8(6):381-402
During the past decade, RGD-peptides have become a popular tool for the targeting of drugs and imaging agents to alphavbeta3-integrin expressing tumour vasculature. RGD-peptides have been introduced by recombinant means into therapeutic proteins and viruses. Chemical means have been applied to couple RGD-peptides and RGD-mimetics to liposomes, polymers, peptides, small molecule drugs and radiotracers. Some of these products show impressive results in preclinical animal models and a RGD targeted radiotracer has already successfully been tested in humans for the visualization of alphavbeta3-integrin, which demonstrates the feasibility of this approach. This review will summarize the structural requirements for RGD-peptides and RGD-mimetics as ligands for alphavbeta3. We will show how they have been introduced in the various types of constructs by chemical and recombinant techniques. The importance of multivalent RGD-constructs for high affinity binding and internalization will be highlighted. Furthermore the in vitro and in vivo efficacy of RGD-targeted therapeutics and diagnostics reported in recent years will be reviewed. 相似文献
45.
Laryngeal Transplantation in 2005: A Review 总被引:3,自引:0,他引:3
M. A. Birchall R. R. Lorenz G. S. Berke E. M. Genden B. H. Haughey M. Siemionow M. Strome 《American journal of transplantation》2006,6(1):20-26
There is no good surgical, medical or prosthetic solution to the problems faced by those with a larynx whose function is irreversibly damaged by tumor or trauma. Over the past 10 years, the pace of research designed to establish laryngeal transplantation as a therapeutic option for these persons has increased steadily. The biggest milestone in this field was the world's first true laryngeal transplant performed in Cleveland, Ohio in 1998. The recipient's graft continues to function well, in many respects, even after 7 years. However, it has also highlighted the remaining barriers to full-scale clinical trials. Stimulated by these observations, several groups have accumulated data which point to answers to some of the outstanding questions surrounding functional reinnervation and immunomodulation. This review seeks to outline the progress achieved in this field by 2005 and to point the way forward for laryngeal transplantation research in the 21st century. 相似文献
46.
围生期窒息发生率和死亡率近10年变迁及相关因素 总被引:2,自引:1,他引:1
目的 分析近10年来围生期窒息发生率和死亡率的变迁,探讨围生期窒息相关因素及开展新法复苏对围生期窒息发生率和死亡率的影响。方法对近10年郑州大学第三附属医院分娩的所有活产新生儿的病历资料进行回顾性分析,计算窒息的发生率、死亡率、病死率,观察上述指标的逐年变化趋势及季节变化的情况,并探讨性别、双/多胎、出生体质量、胎龄分娩方式对这些指标的影响。结果轻度窒息发生率在开展新法复苏后明显下降,并稳定在1.5%左右,而重度窒息的发生率和病死率均无明显变化。窒息儿的发生率以4月份最高,但死亡率和病死率以7月份最高。窒息的发生还与性别、双/多胎、出生体质量、早产以及阴道助产有关。结论围生期窒息的发生与性别、双/多胎、出生体质量、胎龄密切相关;新法复苏能显著降低轻度窒息的发生率,对重度窒息的发生率和窒息病死率无明显影响;窒息儿的死亡率和病死率与季节有关。 相似文献
47.
OBJECTIVE: To determine the mortality of a population of patients diagnosed with Charcot neuropathic osteoarthropathy managed by a single specialist unit and to compare the results with a control population. METHODS: We have undertaken a retrospective analysis of all cases of Charcot foot on the comprehensive database which has been maintained at the specialist diabetic foot clinic at the City Hospital, Nottingham since 1982. Survival and the incidence of amputation (major and minor) was compared with a control population referred with uncomplicated neuropathic ulceration. Controls were individually matched for gender, age (+/-2 years), disease type, disease duration (+/-2 years) and year of referral (+/-3 years). RESULTS: Forty-seven cases (21 female, 26 male) of Charcot foot were identified, of whom 18 (38.3%) had Type 1 diabetes. Mean age and disease duration at presentation were 59.2 +/- 13.4 (sd) and 16.2 +/- 11.2 years, compared with 59.7 +/- 12.6 and 16.3 +/- 11.2 years, respectively, in the controls. Twenty-one (44.7%) of those with Charcot had died, after a mean interval of 3.7 +/- 2.8 years. This compared with 16 (34.0%) after a mean 3.1 +/- 2.7 years in the control group. Mean duration of follow-up in the survivors was 4.7 +/- 4.9 years (Charcot) and 5.3 +/- 3.9 years (controls). A total of 11 (23.4%) Charcot patients had had a major amputation on the side of the index lesion, compared with five (10.6%) controls. There was no difference between the two groups (P > 0.05, Chi-square). CONCLUSIONS: The mortality in this group of patients with Charcot foot was higher than expected. Nevertheless, there was no difference between those with Charcot and those with uncomplicated neuropathic ulceration. It is possible that it is neuropathy, rather than Charcot osteoarthropathy, which is independently associated with increased mortality in diabetes. The mechanism underlying any such association is not known. There is a need for a formal, prospective, multicentre study to investigate the life expectancy and cardiovascular risk of those with Charcot osteoarthropathy. 相似文献
48.
影响肝外伤手术死亡的危险因素分析 总被引:3,自引:1,他引:2
目的分析影响肝外伤手术死亡的危险因素,探讨其临床意义。方法根据AAST和ISS标准,回顾性分析90例肝外伤手术病例,对影响手术死亡的危险因素进行单因素比较和Logistic回归分析。结果死亡15例,其中Ⅲ级2例、Ⅳ级4例、Ⅴ级9例,总体手术死亡率17%。Ⅳ~Ⅴ级肝外伤手术方式的单因素比较提示:清创性肝切除术的相对危险度是0.73;而规则性肝切除术、肝静脉或肝后下腔静脉修补术相对危险度分别是1.32、1.52。Logistic回归分析提示:ISS分会和术中失血量是影响手术死亡率的2个独立因素。结论ISS分值、术中失出血量和手术方式是影响肝外伤手术死亡的3个重要因素,娴熟的手术技能和合理的手术方式可以减少术中出血量和降低手术死亡率。 相似文献
49.
A. J. Esbensen M. M. Seltzer & J. S. Greenberg 《Journal of intellectual disability research : JIDR》2007,51(12):1039-1050
Background Little is known about the mortality of individuals with Down syndrome who have lived at home with their families throughout their lives. The current study evaluates the predictors, causes and patterns of mortality among co‐residing individuals in midlife with Down syndrome as compared with co‐residing individuals with ID owing to other causes. Method This paper examines mortality in 169 individuals with and 292 individuals without Down syndrome from 1988 to 2007. Dates and causes of death were obtained from maternal report, the Social Security Death Index and the National Death Index. Risk factors predicting mortality, including demographic variables, transition variables, and initial and change measures of health, functional abilities and behaviour problems, were obtained from maternal report. Results Having Down syndrome is a risk factor of mortality, net of other risk factors including older age, poorer functional abilities, worsening behaviour problems, residential relocation and parental death. The causes of death among individuals with and without Down syndrome who are in midlife and co‐residing with their families are similar, and are most commonly due to cardiovascular or respiratory problems. Conclusions The findings indicate that midlife adults with Down syndrome who co‐reside with their families generally exhibit similar causes of mortality as do midlife adults with intellectual disability owing to other causes, but show an elevated risk of mortality in midlife net of other variables, such as age and changes in functional abilities and behaviour problems. 相似文献
50.
S.L. CHARLES NGU PETER DUVAL CATHRYN COLLINS 《Journal of Medical Imaging and Radiation Oncology》1992,36(4):321-322
Management of breast cancer during pregnancy is complicated by the high risks of abortion and foetal malformation from the use of radio therapy and chemotherapy. A case of breast cancer during pregnancy, treated with radiotherapy, and the estimated foetal dose is reported. 相似文献